Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder
Crossref DOI link: https://doi.org/10.1007/s10072-015-2368-x
Published Online: 2015-08-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Olivieri, Giorgia
Nociti, Viviana
Iorio, Raffaele
Stefanini, Maria Chiara
Losavio, Francesco Antonio
Mirabella, Massimiliano
Mariotti, Paolo
Text and Data Mining valid from 2015-08-21